{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-259951","form_type":"8-K","ticker":"APLS","cik":"0001492422","company_name":"Apellis Pharmaceuticals, Inc.","filed_at":"2021-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.256412+00:00","generated_at":"2026-06-29T07:00:12.759945+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Apellis appoints Jim Chopas as VP, Corporate Controller and CAO","bullets":["Jim Chopas named VP, Corporate Controller and principal accounting officer, effective August 30, 2021.","Annual base salary of $315,000; target bonus 30% of base; one-time sign-on bonus of $50,000.","Granted option for 21,750 shares and RSU for 7,600 shares, both vesting over four years.","Previously served as VP, principal financial and accounting officer and treasurer at Radius Health."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-259951","json":"https://secwatch.observer/filing/0001193125-21-259951.json","markdown":"https://secwatch.observer/filing/0001193125-21-259951.md","text":"https://secwatch.observer/filing/0001193125-21-259951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492422/000119312521259951/0001193125-21-259951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492422/000119312521259951/d222326d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T07:00:12.759945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"458914736d","claim":"Jim Chopas was appointed as Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer at Apellis Pharmaceuticals, Inc..","evidence_excerpt":"On August 24, 2021, the Board of Directors (the “Board”) of Apellis Pharmaceuticals, Inc. (the “Company”) appointed Jim Chopas, as Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer of the Company, effective as of August 30, 2021 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1492422/000119312521259951/0001193125-21-259951-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}